-
Ibalizumab, sold
under the
brand name Trogarzo, is a non-immunosuppressive
humanised monoclonal antibody that
binds CD4, the
primary receptor for HIV,...
- Adelaide:
Australian Medicines Handbook; 2006. ISBN 0-9757919-2-3 "Trogarzo-
ibalizumab injection, solution". DailyMed. 8
April 2020.
Retrieved 21
September 2020...
- side
effects are diarrhea, vomiting,
runny nose and
other cold symptoms.
Ibalizumab (trade name: Trogarzo) is a new
antiviral drug
specifically for adults...
- | Z Ia–Il | Im–In | Io–Ip | Iq–Ix
ibacitabine (INN)
ibafloxacin (INN)
ibalizumab (INN)
ibandronic acid (INN)
ibazocine (INN)
ibipinabant (USAN, INN) iboctadekin...
- host cell by
blocking one of
several targets. Maraviroc,
enfuvirtide and
Ibalizumab are
available agents in this class.
Maraviroc works by
targeting CCR5...
-
human IL-23 Y
psoriasis Ianalumab mab
human BAFF-R
autoimmune hepatitis Ibalizumab Trogarzo mab
humanized CD4 Y HIV
infection Sintilimab human PD-1 squamous...
- T-20))◊ CCR5 (Maraviroc (MVC) Vicriviroc†, Cenicriviroc†, Leronlimab†) CD4 (
Ibalizumab (IBA), Semzuvolimab§) gp120 (Fostemsavir (FTR))
Integrase inhibitors (Integrase...
-
Durvalumab AstraZeneca UK
unresectable Stage III non-small cell lung
cancer Ibalizumab-uiyk
Theratechnologies human immunodeficiency virus type 1 (HIV-1) infection...
-
Vedolizumab Visilizumab Vobarilizumab TGN1412§
Immune activation:
Dostarlimab Other:
Ibalizumab Chimeric +
humanized Otelixizumab Rozanolixizumab Sutimlimab...
-
Ankylosing spondylitis Psoriatic arthritis Plaque psoriasis 761072 Link
ibalizumab-uiyk
Trogarzo TaiMed Biologics 3/6/18
intravenous humanized CD4 HIV 761065...